A carregar...
Cost-Effectiveness Of The SQ(®) Grass SLIT-Tablet In Children With Allergic Rhinitis: A German Payer Perspective
BACKGROUND: The Grazax Asthma Prevention (GAP) trial has recently demonstrated significant reductions in the odds of asthma symptoms or medication use in patients treated with SQ(®) grass SLIT-tablet relative to placebo, both in combination with allergy and asthma pharmacotherapy. The objective of t...
Na minha lista:
| Publicado no: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842901/ https://ncbi.nlm.nih.gov/pubmed/31807037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S223383 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|